Close Menu

gene expression

Qiagen said that PreAnalytix's PAXgene system is now the only collection, stabilization, and purification method — either automated or manual — available in the US for IVD use.

Using gene expression and copy number analyses of dozens of endometrial cancers, an international research team has turned up characteristic expression profiles and gene amplifications linked to poor outcomes.

For Agilent, the debut of SurePrint G3 caps a year of upgrading its microarray platform. The density upgrade also comes at a time when all other major array companies have made similar improvements with their platforms.

In Print: Mar 3, 2009

Premium

Microarray-Related Papers of Note, February 2009

BioArray Briefs: 2009.03.03

Premium

Febit, READNA Consortium, US Department of Agriculture, Autogenomics, Oxford Gene Technology, Optra, Gene Logic, Genstruct, Global Biomarker Conference

The company has launched a new personal genomics service designed to provide cancer patients with information about specific treatment options that their physicians might otherwise overlook.

Oxford Gene Tech, Optra Systems, Genedata, Syngenta, Floragenex, National Center for Genome Resources, GenoLogics, Genstruct, Gene Logic, Arizona Biomedical Research Commission, 5AM Solutions

The Umbrella Institute

Premium

The Hunter Medical Research Institute was started to bring together biomedical and clinical scientists — and the results have been so positive that it has become a model for how to accomplish translational research.

In doing so, SIROCCO is meeting its goal of making its discoveries and technologies freely accessible to the research community.

IP Update: Feb 26, 2009

Premium

USPTO Publishes Six RNAi-Related Patent Applications

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.